IL6 and asthma: Although elevated IL-6 has long been considered a general marker of inflammation, Naik et al. suggest that IL-6 is not just a proinflammatory marker, but a key factor that contributes to the pathogenesis of some important inflammatory diseases, including asthma; it may hence serve as both a biomarker and a therapeutic target for asthma [10, 50].